Skip to main content
. 2022 Sep 2;12:818283. doi: 10.3389/fonc.2022.818283

Figure 2.

Figure 2

The prognostic value of CASP6 in the CGGA database. (A) Kaplan-Meier survival analyses of overall survival and CASP6 in patients with glioma in the CGGA database. (B) ROC curve analysis to evaluate the prognostic value of CASP6 expression in glioma in terms of survival at 3 years and 5 years. (C) AUC analysis to evaluate the prognostic value of CASP6 expression in glioma.